The role of pharmacogenetic variation in metoprolol CYP2D6 genotypes polymorphism

QR Code

The role of pharmacogenetic variation in metoprolol CYP2D6 genotypes polymorphism

Bibliographic Details
Main Authors:	Wan Sulaiman, Wan Mohd. Azizi, Abdul Razak, Tariq, Lay, Kek Teh, Ismail, Rusli
Format:	Book Chapter
Language:	English
Published:	IIUM Press 2011
Subjects:	RS Pharmacy and materia medica
Online Access:	http://irep.iium.edu.my/20298/ http://irep.iium.edu.my/20298/1/Chapter_10.pdf

Similar Items

Tacrolimus pharmacogenetics: the influence of genetic polymorphisms of CYP3A5, MDRl and Pregnane X Receptor (PXR) in transplant patients / Professor Dr. Mohd Zaki Salleh and Associate Prof. Dr Teh Lay Kek
by: Salleh, Mohd Zaki, et al.
Published: (2010)

Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8
by: Abu Bakar, Ruzilawati
Published: (2008)

CYP2C9 polymorphism: prevalence in healthy and warfarin-treated Malay and Chinese in Malaysia
by: Ngow, Harris Abdullah, et al.
Published: (2009)

Genetic polymorphism of drug metabolizing enzymes and estrogen receptor in pharmacogenetics of tamoxifen: implication for optimization of breast cancer treatment / Teh Lay Kek and Mohd Zaki Salleh
by: Lay Kek, Teh, et al.
Published: (2010)

Genetic polymorphism of CYP2C9 in patients on warfarin therapy and the clinical relevance / Teh Lay Kek... [et al.]
by: Teh, Lay Kek, et al.
Published: (2007)

Influence Of Cyp2d6 And Drd2 Polymorphisms On Clinical Outcomes Of Patients With Schizophrenia
by: Zahari, Zalina
Published: (2009)

The Risk of Recurrence in Breast Cancer Patients Treated with Tamoxifen: Polymorphisms of CYP2D6 and ABCB1
by: Teh, L. K., et al.
Published: (2011)

Genetic Polymorphism of CYP2D6 and MDR1 in breast cancer patients treated with tamoxifen
by: Mohamad, NI, et al.
Published: (2010)

CYP2D6 genetic polymorphisms and phenotypes in different ethnicities of Malaysian breast cancer patients
by: Fee, Wai Chin, et al.
Published: (2016)

Cloning and expression of CYP2D6*1 and CYP2D6*10 and its application in vitro drug-herbs interaction studies
by: Lee, Wee Leng
Published: (2013)

The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
by: Amin, Arwa M., et al.
Published: (2017)

Genetic Polymorphisms In The CYP2A6: Implications For Inter-Individual Differences In Nicotine Metabolism
by: Musa, Nurfadhlina
Published: (2006)

Pipeline pharmacogenetics: A novel approach to integrating pharmacogenetics into drug development
by: Akkari, Patrick, et al.
Published: (2009)

Genetic polymorphisms of cyp3a4 and cyp2c8 in heal thy volunteers administered with repaglinide
by: Gan Siew, Hua
Published: (2008)

Metabolomics and pharmacogenetics based 5-fluorouracil monitoring in colorectal cancer patients
by: Bannur, Zakaria, et al.
Published: (2014)

Pharmacogenetics of CYP450A, ABCB1, ABCC2, SLCO1B3 gene polymorphisms and plasma alpha-1-acid glycoprotein level on nonhaematological adverse events of docetaxel in Malaysian breast cancer patients
by: Jabir, Rafid Salim
Published: (2015)

Genetic polymorphisms of CYP 3A4 & CYP2C8 in healthy volunteers title of project administered with repaglinide
by: Hua, Gan Siew
Published: (2008)

Pharmacogenetics, pharmacogenomics and airway disease
by: Hall, Ian P.
Published: (2002)

Mutational analysis of CYP2C8 in hypertensive patients using denaturing high performance liquid chromatography.
by: Teh, Lay Kek, et al.
Published: (2010)

Metoprolol for prophylaxis of postoperative atrial fibrillation in cardiac surgery patients: systematic review and meta-analysis
by: Mohd, Noor Norhayati, et al.
Published: (2020)

Role of pharmacodiagnostic of CYP2C9 variants in the optimization of warfarin therapy in Malaysia: a 6-month follow-up study
by: Ngow, Harris Abdullah, et al.
Published: (2008)

The influence of genetic polymorphisms of CYP3A on the pharmacokinetic variation and clinical outcomes of tacrolimus in a cohort of patients / Mohd Rahimi Muda
by: Muda, Mohd Rahimi
Published: (2014)

Contribution of CYP2E1 polymorphism to aging in the mechanical workshop workers
by: Eshkoor, Sima Ataollahi, et al.
Published: (2013)

A review on CYP11A1, CYP17A1, and CYP19A1 polymorphism studies: candidate susceptibility genes for polycystic ovary syndrome (PCOS) and infertility
by: Heidarzadehpilehrood, Roozbeh, et al.
Published: (2022)

The impact of CYP3A4 and CYP3A5 polymorphisms on anastrozole's pharmacokinetics and pharmacodynamics in post-menopausal breast cancer patients
by: Abubakar, Murtala Bello
Published: (2017)

A Study On Cyp2c19 Genetic Variations Of Clopidogrel And Ticagrelor Treatment Among Coronary Artery Disease (CAD) Patients Undergoing Percutaneous Coronary Intervention (PCI)
by: Ak-Kaif, Mohammed Ahmed Imran
Published: (2023)

Sunlight mediated enhanced removal of metoprolol using graphitic carbon nitride (g-C3N4)
by: Khew, Chung Wei, et al.
Published: (2023)

A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure
by: Ward, Natalie, et al.
Published: (2008)

Pharmacogenetics in cardiovascular disorders: An update on the principal drugs
by: Predazzi, I., et al.
Published: (2013)

Pharmacogenetics of beta adrenergic blockers: their clinical significance
by: Elsayed, Tarek Mohamed Ali
Published: (2009)

A pharmacogenetic study of cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase complex 1 (VKORCl) / Immaculate Mbongo Langmia
by: Mbongo Langmia, Immaculate
Published: (2011)

Imatinab mesylate treatment in Chronic Myeloid Leukemia (CML)- understanding the fundamental pharmacokinetic and pharmacogenetic mechanisms for variation in response
by: Ankathil, Ravindran
Published: (2016)

Polymorphic crystals and their characterisation
by: Abu Bakar, Mohd Rushdi, et al.
Published: (2011)

Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia
by: Ware, James S., et al.
Published: (2017)

A CYP26B1 polymorphism enhances retinoic acid catabolism and may aggravate atherosclerosis.
by: Krivospitskaya, O., et al.
Published: (2012)

Metabolomics and pharmacogenetics based 5-fluorouracil monitoring in colorectal cancer patients
by: Zakaria, Bannur, et al.
Published: (2014)

Metbod Development of Allele Specific PCR Assay for CYP2B6
by: Mohd Iqbal, Zulkafli
Published: (2009)

Lack of correlation between INR and warfarin dose: a role of pharmacogenotyping of CYP2C9*3 and VKORC1 for anticoagulation
by: Salleh, Mohd Zaki, et al.
Published: (2009)

In vitro study of modulatory effects of Strobilanthes crispus extracts on human cDNA-expressed cytochrome P450 2A6 (CYP2A6) and CYP3A4
by: pan, Yan, et al.
Published: (2016)

Association of SLC6A4 gene polymorphisms with Schizophrenia
by: Aladzemi, Farah Wahida, et al.
Published: (2015)